Dianthus Therapeutics, Inc. /DE/ Operating Cash Flow
Dianthus Therapeutics, Inc. /DE/ (DNTH) reported Operating Cash Flow of -$77.84 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-04
- Dianthus Therapeutics, Inc. /DE/ net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$48.98M.
- Dianthus Therapeutics, Inc. /DE/ net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$28.86M.
- Dianthus Therapeutics, Inc. /DE/ net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$46.98M.
- Dianthus Therapeutics, Inc. /DE/ net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$30.55M.
- Dianthus Therapeutics, Inc. /DE/ net cash provided by (used in) operating activities for fiscal 2025 was -$129.06M.
- Dianthus Therapeutics, Inc. /DE/ net cash provided by (used in) operating activities for fiscal 2024 was -$78.18M.
- Dianthus Therapeutics, Inc. /DE/ net cash provided by (used in) operating activities for fiscal 2023 was -$36.86M.
- Dianthus Therapeutics, Inc. /DE/ net cash provided by (used in) operating activities for fiscal 2022 was -$29.07M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$48.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | -$77.84M 10-Q · filed 2026-08-04 | -$124.82M derived: sum of 3 quarters · filed 2026-08-04 | -$155.38M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2026-03-31 | -$28.86M 10-Q · filed 2026-05-05 | -$75.84M derived: sum of 2 quarters · filed 2026-05-05 | -$106.39M derived: sum of 3 quarters · filed 2026-05-05 | -$130.29M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-12-31 | -$46.98M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | -$77.54M derived: sum of 2 quarters · filed 2026-03-09 | -$101.43M derived: sum of 3 quarters · filed 2026-08-04 | -$129.06M 10-K · filed 2026-03-09 | ||||
| 2025-09-30 | -$30.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$54.45M derived: sum of 2 quarters · filed 2026-08-04 | -$82.08M 10-Q · filed 2025-11-05 | -$109.52M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-06-30 | -$23.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | -$51.52M 10-Q · filed 2026-08-04 | -$78.97M derived: sum of 3 quarters · filed 2026-08-04 | -$100.23M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-03-31 | -$27.63M 10-Q · filed 2026-05-05 | -$55.07M derived: sum of 2 quarters · filed 2026-05-05 | -$76.34M derived: sum of 3 quarters · filed 2026-05-05 | -$90.87M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | -$27.44M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | -$48.71M derived: sum of 2 quarters · filed 2026-03-09 | -$63.24M derived: sum of 3 quarters · filed 2026-03-09 | -$78.18M 10-K · filed 2026-03-09 | ||||
| 2024-09-30 | -$21.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$35.80M derived: sum of 2 quarters · filed 2025-11-05 | -$50.74M 10-Q · filed 2025-11-05 | -$62.59M derived: sum of 4 quarters · filed 2025-11-05 | ||||
| 2024-06-30 | -$14.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$29.47M 10-Q · filed 2025-08-07 | -$41.32M derived: sum of 3 quarters · filed 2025-08-07 | -$51.31M derived: sum of 4 quarters · filed 2025-08-07 | ||||
| 2024-03-31 | -$14.94M 10-Q · filed 2025-05-12 | -$26.80M derived: sum of 2 quarters · filed 2025-05-12 | -$36.79M derived: sum of 3 quarters · filed 2025-05-12 | -$41.52M derived: sum of 4 quarters · filed 2025-05-12 | ||||
| 2023-12-31 | -$11.85M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | -$21.85M derived: sum of 2 quarters · filed 2025-03-11 | -$26.58M derived: sum of 3 quarters · filed 2025-03-11 | -$36.86M 10-K · filed 2025-03-11 | ||||
| 2023-09-30 | -$9.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$14.72M derived: sum of 2 quarters · filed 2024-11-07 | -$25.01M 10-Q · filed 2024-11-07 | -$33.86M derived: sum of 4 quarters · filed 2024-11-07 | ||||
| 2023-06-30 | -$4.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$15.02M 10-Q · filed 2024-08-08 | -$42.14M 10-Q · filed 2023-08-03 | -$23.87M derived: sum of 3 quarters · filed 2024-08-08 | -$7.49M derived: sum of 4 quarters · filed 2024-08-08 | |||
| 2023-03-31 | -$10.28M 10-Q · filed 2024-05-09 | -$35.60M 10-Q · filed 2023-05-15 | -$19.14M derived: sum of 2 quarters · filed 2024-05-09 | -$2.76M derived: sum of 3 quarters · filed 2024-05-09 | -$19.61M derived: sum of 4 quarters · filed 2024-05-09 | |||
| 2022-12-31 | -$8.85M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $7.52M derived: sum of 2 quarters · filed 2024-03-21 | -$9.33M derived: sum of 3 quarters · filed 2024-03-21 | -$29.07M 10-K · filed 2024-03-21 | -$67.09M 10-K · filed 2023-03-23 | |||
| 2022-09-30 | $16.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$478.00K derived: sum of 2 quarters · filed 2023-11-09 | -$20.22M 10-Q · filed 2023-11-09 | -$50.40M 10-Q · filed 2022-11-03 | $13.72M derived: sum of 4 quarters · filed 2023-12-21 | |||
| 2022-06-30 | -$16.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$36.59M 10-Q · filed 2023-08-03 | -$2.66M derived: sum of 3 quarters · filed 2023-12-21 | -$16.72M derived: sum of 4 quarters · filed 2023-12-21 | ||||
| 2022-03-31 | -$19.74M 10-Q · filed 2023-05-15 | $14.20M derived: sum of 2 quarters · filed 2023-12-21 | $129.00K derived: sum of 3 quarters · filed 2023-12-21 | -$12.87M derived: sum of 4 quarters · filed 2023-12-21 | ||||
| 2021-12-31 | $33.94M derived: 8-K 12 month − 10-Q 9 month · filed 2023-12-21 | $19.87M derived: sum of 2 quarters · filed 2023-12-21 | $6.87M derived: sum of 3 quarters · filed 2023-12-21 | -$9.90M 8-K · filed 2023-12-21 | -$59.53M 10-K · filed 2022-03-08 | |||
| 2021-09-30 | -$14.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$27.07M derived: sum of 2 quarters · filed 2022-11-03 | -$43.84M 10-Q · filed 2022-11-03 | -$57.57M derived: sum of 4 quarters · filed 2022-11-03 | ||||
| 2021-06-30 | -$13.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$29.77M 10-Q · filed 2022-08-04 | -$43.51M derived: sum of 3 quarters · filed 2022-08-04 | -$57.94M derived: sum of 4 quarters · filed 2022-08-04 | ||||
| 2021-03-31 | -$16.77M 10-Q · filed 2022-05-16 | -$30.51M derived: sum of 2 quarters · filed 2022-05-16 | -$44.94M derived: sum of 3 quarters · filed 2022-05-16 | -$64.14M derived: sum of 4 quarters · filed 2022-05-16 | ||||
| 2020-12-31 | -$13.73M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | -$28.16M derived: sum of 2 quarters · filed 2022-03-08 | -$47.37M derived: sum of 3 quarters · filed 2022-03-08 | -$64.02M 10-K · filed 2022-03-08 | ||||
| 2020-09-30 | -$14.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$33.63M derived: sum of 2 quarters · filed 2021-11-04 | -$50.29M 10-Q · filed 2021-11-04 | -$65.92M derived: sum of 4 quarters · filed 2021-11-04 | ||||
| 2020-06-30 | -$19.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$35.86M 10-Q · filed 2021-08-05 | -$51.49M derived: sum of 3 quarters · filed 2021-08-05 | -$63.00M derived: sum of 4 quarters · filed 2021-08-05 | ||||
| 2020-03-31 | -$16.66M 10-Q · filed 2021-05-06 | -$32.28M derived: sum of 2 quarters · filed 2021-05-06 | -$43.79M derived: sum of 3 quarters · filed 2021-05-06 | -$58.82M derived: sum of 4 quarters · filed 2021-05-06 | ||||
| 2019-12-31 | -$15.63M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-03 | -$27.13M derived: sum of 2 quarters · filed 2021-03-03 | -$42.17M derived: sum of 3 quarters · filed 2021-03-03 | -$57.10M 10-K · filed 2021-03-03 | ||||
| 2019-09-30 | -$11.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$26.54M derived: sum of 2 quarters · filed 2020-11-05 | -$41.48M 10-Q · filed 2020-11-05 | -$54.10M derived: sum of 4 quarters · filed 2020-11-05 | ||||
| 2019-06-30 | -$15.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$29.97M 10-Q · filed 2020-08-06 | -$42.59M derived: sum of 3 quarters · filed 2020-08-06 | -$53.14M derived: sum of 4 quarters · filed 2020-08-06 | ||||
| 2019-03-31 | -$14.94M 10-Q · filed 2020-05-07 | -$27.56M derived: sum of 2 quarters · filed 2020-05-07 | -$38.11M derived: sum of 3 quarters · filed 2020-05-07 | -$47.22M derived: sum of 4 quarters · filed 2020-05-07 | ||||
| 2018-12-31 | -$12.62M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-03 | -$23.17M derived: sum of 2 quarters · filed 2020-03-03 | -$32.28M derived: sum of 3 quarters · filed 2020-03-03 | -$41.89M 10-K · filed 2020-03-03 | ||||
| 2018-09-30 | -$10.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | -$19.66M derived: sum of 2 quarters · filed 2019-11-13 | -$29.26M 10-Q · filed 2019-11-13 | -$37.49M derived: sum of 4 quarters · filed 2020-03-03 | ||||
| 2018-06-30 | -$9.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$18.71M 10-Q · filed 2019-08-08 | -$26.95M derived: sum of 3 quarters · filed 2020-03-03 | -$32.39M derived: sum of 4 quarters · filed 2020-03-03 | ||||
| 2018-03-31 | -$9.60M 10-Q · filed 2019-05-09 | -$17.84M derived: sum of 2 quarters · filed 2020-03-03 | -$23.28M derived: sum of 3 quarters · filed 2020-03-03 | |||||
| 2017-12-31 | -$8.23M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-03 | -$13.68M derived: sum of 2 quarters · filed 2020-03-03 | -$22.26M 10-K · filed 2020-03-03 | |||||
| 2017-09-30 | -$5.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$14.03M 10-Q · filed 2018-11-08 | ||||||
| 2017-06-30 | -$8.59M 10-Q · filed 2018-08-09 | |||||||
| 2016-12-31 | -$6.53M 10-K · filed 2019-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |